1-2 of 2
Georgi Kojouharoff, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two Years Rituximab Maintenance Vs. Observation after First Line Treatment with Bendamustine Plus Rituximab (B-R) in Patients with Waldenström's Macroglobulinemia (MW): Results of a Prospective, Randomized, Multicenter Phase 3 Study (the StiL NHL7-2008 MAINTAIN trial)

Mathias J Rummel, MD PhD, Christian Lerchenmüller, MD, Manfred Hensel, MD, Martin Goerner, MD, Christian Buske, MD PhD, Holger Schulz, Burkhard Schmidt, MD, Georgi Kojouharoff, MD, Elisabeth Lange, MD, Wolfgang Willenbacher, MD PhD, Jan Dürig, Erik Engel, Frank Kauff, Jürgen Barth, Alexander Christoph Burchardt, MD, Axel Hinke, PhD, Jasmin Wupperfeld, Richard Greil, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 343.
https://doi.org/10.1182/blood-2019-121909
Published: 2019
Journal Articles

Bortezomib and Low-Dose Dexamethasone with or without Continuous Low-Dose Oral Cyclophosphamide for Primary Refractory or Relapsed Multiple Myeloma: Final Results of a National Multicenter Randomized Controlled Phase III Study

Martin Kropff, MD, Martin Vogel, MD PhD, Andrea Kreter, Dipl. Stat., Rudolf Schlag, Lothar Müller, MD, Rudolf Weide, MD, Wolfgang Knauf, MD PhD, Thomas Decker, MD, Heinrich Fiechtner, PhD, Georgi Kojouharoff, MD, Stephan Kremers, MD, Wolfgang E Berdel, MD
Journal: Blood
Blood (2014) 124 (21): 3470.
https://doi.org/10.1182/blood.V124.21.3470.3470
Published: 2014